What is the current Price Target for the Mesoblast Limited Sponsored ADR stock?

The average Mesoblast Limited Sponsored ADR target price is $25.55. This is 64.40% higher than the current stock price. The highest price target is 125.54%, the lowest is -7.84%. 5 Analysts have issued a price target Mesoblast Limited Sponsored ADR 2026 .

How high will the Mesoblast Limited Sponsored ADR stock rise?

No reliable answer can be given as to how high the Mesoblast Limited Sponsored ADR stock will rise. The performance of stocks, including the Mesoblast Limited Sponsored ADR stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Mesoblast Limited Sponsored ADR stock today?

The performance of Mesoblast Limited Sponsored ADR stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Mesoblast Limited Sponsored ADR stock fall?

The decline in Mesoblast Limited Sponsored ADR stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Mesoblast Limited Sponsored ADR Forecast, price target & analysts

$17.01

9.46% today

Nasdaq, Feb 28, 08:47 pm CET

ISIN

US5907171046

Symbol

MESO

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Mesoblast Limited Sponsored ADR Target price 2025 - Analyst rating & recommendation

Mesoblast Limited Sponsored ADR Classifications & Recommendation:

Buy

83%

Hold

17%

Mesoblast Limited Sponsored ADR Price Target

Target Price	$25.55
Price	$15.54
Potential	64.40% register free of charge
Number of Estimates	5

	5 Analysts have issued a price target Mesoblast Limited Sponsored ADR 2026 . The average Mesoblast Limited Sponsored ADR target price is $25.55. This is 64.40% register free of charge higher than the current stock price. The highest price target is $35.05 125.54% register free of charge , the lowest is $14.32 7.84% register free of charge .
	A rating was issued by 6 analysts: 5 Analysts recommend Mesoblast Limited Sponsored ADR to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Mesoblast Limited Sponsored ADR stock has an average upside potential 2026 of 64.40% register free of charge . Most analysts recommend the Mesoblast Limited Sponsored ADR stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Annually

	Jun '24	2025 Estimates
Revenue Million $	5.90	57.93
	21.33%	881.80%
EBITDA Margin	-918.14%	-15.19%
	0.25%	98.35%

5 Analysts have issued a sales forecast Mesoblast Limited Sponsored ADR 2025 . The average Mesoblast Limited Sponsored ADR sales estimate is

Unlock

. This is

Unlock

than the revenue of the last 12 months(TTM). The highest sales forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics:

2024	$5.9m	21.33%
2025	$57.9m 881.80% Unlock
2026	$383m 560.64% Unlock
2027	$780m 103.78% Unlock
2028	$1.8b 127.61% Unlock
2029	$735m 58.57% Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Annually

	Jun '24	2025 Estimates
Earnings Per Share $	-0.89	-0.73
	15.24%	17.98%
P/E		negative
EV/Sales		35.59

3 Analysts have issued a Mesoblast Limited Sponsored ADR forecast for earnings per share. The average Mesoblast Limited Sponsored ADR <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-0.89	15.24%
2025	$-0.73 17.98% Unlock
2026	$-0.21 71.23% Unlock
2027	$0.55 361.90% Unlock
2028	$0.48 12.73% Unlock
2029	$2.33 385.42% Unlock

Current	-16.76	750.76%
2025	-21.39 27.63% Unlock
2026	-72.84 240.53% Unlock
2027	28.25 138.78% Unlock
2028	32.38 14.62% Unlock
2029	6.67 79.40% Unlock

Based on analysts' sales estimates for 2025, the Mesoblast Limited Sponsored ADR stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

Unlock

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of

Unlock

This results in the following potential growth metrics and future valuations:

Current	364.25	992.86%
2025	35.59 90.23% Unlock
2026	5.39 84.86% Unlock
2027	2.64 50.93% Unlock
2028	1.16 56.07% Unlock
2029	2.80 141.38% Unlock

Current	348.69	1,169.20%
2025	34.07 90.23% Unlock
2026	5.16 84.86% Unlock
2027	2.53 50.93% Unlock
2028	1.11 56.07% Unlock
2029	2.68 141.37% Unlock

Mesoblast Limited Sponsored ADR...

Current Mesoblast Limited Sponsored ADR Upgrades & Downgrades Beta

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
PIPER SANDLER COMPANIES	Locked ➜ Locked	Locked	Dec 19 2024
MAXIM GROUP	Locked ➜ Locked	Locked	Dec 18 2024
BELL POTTER SECURITIES	Locked ➜ Locked	Locked	Aug 28 2024

Analyst Rating	Date
Locked PIPER SANDLER COMPANIES: Locked ➜ Locked	Dec 19 2024
Locked MAXIM GROUP: Locked ➜ Locked	Dec 18 2024
Locked BELL POTTER SECURITIES: Locked ➜ Locked	Aug 28 2024

Discover more stocks with a high price target

Coinbase Global, Inc. 60.51%

BioNTech SE - ADR 30.07%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now